Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease-Reference-Cited by-同舟云学术

Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease

Published:2009-08-07 Issue:22 Volume:30 Page:2742-2748
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:European Heart Journal

Author:

Koenig W.,Vossen C. Y.,Mallat Z.,Brenner H.,Benessiano J.,Rothenbacher D.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/30/22/2742/1293977/ehp302.pdf

Reference17 articles.

1. Phospholipase A 2 in Vascular Disease

2. Mildly Oxidized LDL Induces Expression of Group IIa Secretory Phospholipase A 2 in Human Monocyte–Derived Macrophages

3. Regulation of secretory type-II phospholipase A2 and of lysophosphatidic acid synthesis

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endocrine regulation of phospholipase as a therapeutic target for cardiovascular diseases;Phospholipases in Physiology and Pathology;2023

2. DNA methylome profiling reveals epigenetic regulation of lipoprotein-associated phospholipase A2 in human vulnerable atherosclerotic plaque;Clinical Epigenetics;2021-08-21

3. Group IIA Secretory Phospholipase A2 Predicts Graft Failure and Mortality in Renal Transplant Recipients by Mediating Decreased Kidney Function;Journal of Clinical Medicine;2020-04-29

4. Group IIA Secretory Phospholipase A 2 , Vascular Inflammation, and Incident Cardiovascular Disease;Arteriosclerosis, Thrombosis, and Vascular Biology;2019-06

5. Mendelian Randomization Studies Promise to Shorten the Journey to FDA Approval;JACC: Basic to Translational Science;2018-10